Snyderman Ralph
SEC-identified person · CIK 1178031 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Irhythm Technologies, Inc. IRTC | Director | filed 2017–2025 |
| Caredx, Inc. CDNA | Director | filed 2014–2022 |
| Liquidia Technologies Inc LQDA | Director | filed 2018–2020 |
| Argos Therapeutics INC ARGS | Director | filed 2016–2017 |
| Press Ganey Holdings, Inc. PGND | Director | filed 2015–2016 |
| Targacept INC TRGT | Director | filed 2007–2012 |
| Pharmaceutical Product Development INC PPDI | Director | filed 2011–2011 |
| Procter & Gamble Co PG | Director | filed 2006–2010 |
| Torreypines Therapeutics, Inc. TPTX | Director | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.